All systems operational
Q1 2026

Molecular mechanism of compound anisodine in improving ischemic ophthalmopathy by regulating AMPK/mTOR pathway

Weijie Yang · Jing Chen · Zhengrong Shen · Hong Xu
10.1016/j.jrras.2026.102397 401 Views 0 Citations
0
Citations
401
Views
Abstract not available for this publication.
Cite this Article (APA)
Weijie, Y., Jing, C., Zhengrong, S., Hong, X. (2026). Molecular mechanism of compound anisodine in improving ischemic ophthalmopathy by regulating AMPK/mTOR pathway. Journal of Radiation Research and Applied Sciences. https://doi.org/10.1016/j.jrras.2026.102397
Related Papers
2
cites
415
Analysis of photon shielding properties and buildup factors of epoxy composites reinforced with tita…
Nermeen S. Gaballah; Mona M. Gouda; Dina G. Yakot; Walaa M.R. Alahmade; Abdallah · 2026
1
cites
422
Bayesian and non-Bayesian inference for the inverse power induced XLindley distribution with applica…
Hadeel AlQadi; Diaa S. Metwally; Raga Idress; Ahmed M. Felifel · 2026
1
cites
419
0
cites
426
Access
View Full Text via DOI
Published in
ISSN 1687-8507
Quartile Q1
AMS Score 100
Field Natural Sciences
Publisher Elsevier / Egyptian Society of Radi
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 24 Jul 2026